Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.

Saved in:
Bibliographic Details
Title: Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.
Authors: An, Xin1,2, Wang, Feng-Hua1,2, Ding, Pei-Rong2, Deng, Ling2,3, Jiang, Wen-Qi1,2, Zhang, Li1,2, Shao, Jian-Yong2,3, Li, Yu-Hong1,3
Source: Cancer (0008543X). Aug2011, Vol. 117 Issue 16, p3750-3757. 8p.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.25932